Is Hypomagnesemia a Risk Factor for Atherogenic Dyslipidemia in Patients with Chronic Kidney Disease?
Objective: Atherosclerosis, which starts from early stages of chronic kidney disease (CKD), is an important cause for increased morbidity and mortality. We aimed to investigate whether hypomagnesemia is a marker of increased atherogenic dyslipidemia in patients with CKD with a glomerular filtration...
Main Authors: | Sümeyye Kılıç, Osman Maviş, Banu Böyük |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2021-04-01
|
Series: | Cam & Sakura Medical Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=csmedj&un=CSM-21931 |
Similar Items
-
Association between Chronic Periodontitis and Serum Lipid Levels with its Risk to Atherosclerosis
by: Kush Pathak, et al.
Published: (2014-01-01) -
Clinical Effect of Poly Herbal Unani Formulation on Dyslipidemia- A Randomized Trial
by: Khairul Alam, et al.
Published: (2023-10-01) -
Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
by: Michel Farnier
Published: (2008-10-01) -
Higher Dietary Vitamin D Intake Influences the Lipid Profile and hs-CRP Concentrations: Cross-Sectional Assessment Based on The National Health and Nutrition Examination Survey
by: Zahra Hariri, et al.
Published: (2023-02-01) -
Association between Adipose Tissue Depots and Dyslipidemia: The KORA-MRI Population-Based Study
by: Ricarda von Krüchten, et al.
Published: (2022-02-01)